Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis
Blood · 20.08.2026 · 148 (8) · 1011-1025
DOI: 10.1182/blood.2026033320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, erschienen am 20.08.2026. Verfasst von Kristie T Bariboloka und 30 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany. Hauptthemen laut MEDLINE: CASP8 and FADD-Like Apoptosis Regulating Protein, Lymphoma, Large B-Cell, Diffuse, B-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous malignant disease that remains a major clinical challenge, as relapsed and refractory disease is difficult to treat. Apoptosis evasion is a major feature of DLBCL. However, while the suppression of intrinsic apoptosis has long been recognized as a lymphoma-promoting event, the role of extrinsic apoptosis has remained poorly defined. In this study, we demonstrated at the genetic level that expression of cellular Fas-associated death domain protein-like IL-1β-converting enzyme-inhibitory protein (cFLIP), the most crucial, non-redundant inhibitor of extrinsic apoptosis, in B cells is necessary for the development of DLBCL in an autochthonous murine model. Indeed, B-cell–specific deletion of Cflar, the gene encoding for cFLIP, prevented lymphomagenesis mediated by oncogenic Myd88 and overexpression of BCL2. In human lymphoma cells, we showed that the absence of cFLIP sensitized activated B-cell–like (ABC)- but not germinal center B-cell–like (GCB)-DLBCL subtype cells to TRAIL- or lipopolysaccharide-induced, caspase-8–mediated apoptosis. Furthermore, we unveiled a cell death–independent role of cFLIP in the suppression of proinflammatory cytokines at the transcriptional level, selectively in the ABC subtype. These results indicate that the suppression of intrinsic apoptosis can support lymphomagenesis only if extrinsic apoptosis is properly controlled. Moreover, licensing extrinsic apoptosis through CFLAR deletion can efficiently promote death in DLBCL cells, despite the suppression of the intrinsic pathway. Overall, these data provide a rationale for the development of cFLIP inhibitors for the treatment of ABC-DLBCL and possibly other hematological cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
- Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany.
- Institute for Developmental Immunology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
- Department of Hematology and Oncology, Goethe University Frankfurt, University Hospital Frankfurt am Main, Frankfurt, Germany.
- Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.
- Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
ORCID-Profile: Kristie T Bariboloka, Santiago Serrano-Saenz, Deniz Pinar Savcigil, Sarah Spöck, Luca D Schreurs, Nazli Serin, Justinas Valiulis, Kalvin Nugraha, Giulia Gangarossa, Anna Lütz, Moritz Reese, Sebastian Klein, Hamid Kashkar, Martin Peifer, Björn Chapuy, Gero Knittel, Verena Labi, Phuong-Hien Nguyen, Ron D Jachimowicz, Michael Hallek, Hans Christian Reinhardt, Alessandro Annibaldi
Zitieren
APA
Bariboloka, K. T., Serrano-Saenz, S., Savcigil, D. P., Spöck, S., Poss, R. E., Schreurs, L. D., Löber, J., Serin, N., Valiulis, J., Nugraha, K., Gangarossa, G., Lütz, A., Reese, M., Klein, S., Enssle, J. C., Buettner, R., Kashkar, H., Peifer, M., Chapuy, B., …, & Annibaldi, A. (2026). Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis. Blood, 148(8), 1011-1025. https://doi.org/10.1182/blood.2026033320
Vancouver
Bariboloka KT, Serrano-Saenz S, Savcigil DP, Spöck S, Poss RE, Schreurs LD, et al. Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis. Blood. 2026;148(8):1011-1025. doi:10.1182/blood.2026033320
BibTeX
@article{Bariboloka2026,
author = {Bariboloka, Kristie T and Serrano-Saenz, Santiago and Savcigil, Deniz Pinar and Spöck, Sarah and Poss, Rebecca E and Schreurs, Luca D and Löber, Jens and Serin, Nazli and Valiulis, Justinas and Nugraha, Kalvin and Gangarossa, Giulia and Lütz, Anna and Reese, Moritz and Klein, Sebastian and Enssle, Julius C and Buettner, Reinhard and Kashkar, Hamid and Peifer, Martin and Chapuy, Björn and Knittel, Gero and Labi, Verena and Villunger, Andreas and Nguyen, Phuong-Hien and Scheich, Sebastian and Oellerich, Thomas and Walczak, Henning and Flümann, Ruth and Jachimowicz, Ron D and Hallek, Michael and Reinhardt, Hans Christian and Annibaldi, Alessandro},
title = {Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis},
journal = {Blood},
year = {2026},
volume = {148},
number = {8},
pages = {1011--1025},
doi = {10.1182/blood.2026033320}
}
EUVIMED